Home
>
National Drug Code (NDC)
>
LIPOFEN
LIPOFEN - 66869-137-20 - (fenofibrate)
Drug Information of LIPOFEN
| Product NDC: | 66869-137 |
| Proprietary Name: | LIPOFEN |
| Non Proprietary Name: | fenofibrate |
| Active Ingredient(s): | 50 mg/1 & nbsp; fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LIPOFEN
| Product NDC: | 66869-137 |
| Labeler Name: | Kowa Pharmaceuticals America Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021612 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071001 |
Package Information of LIPOFEN
| Package NDC: | 66869-137-20 |
| Package Description: | 30 CAPSULE in 1 BOTTLE, PLASTIC (66869-137-20) |
NDC Information of LIPOFEN
| NDC Code | 66869-137-20 |
| Proprietary Name | LIPOFEN |
| Package Description | 30 CAPSULE in 1 BOTTLE, PLASTIC (66869-137-20) |
| Product NDC | 66869-137 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fenofibrate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20071001 |
| Marketing Category Name | NDA |
| Labeler Name | Kowa Pharmaceuticals America Inc. |
| Substance Name | FENOFIBRATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
